Demographic and clinical characteristics of 2857 survivors of blood or marrow transplantation
| Variables . | n (%) . |
|---|---|
| Sex | |
| Male | 1535 (53.7%) |
| Age at study participation in years | |
| Median (interquartile range [IQR]) | 47 (30-58) |
| Time from transplant in years | |
| Median (IQR) | 9 (5-16) |
| Race/ethnicity, n (%) | |
| Non-Hispanic White | 2176 (76.2%) |
| Black or African American | 136 (4.8%) |
| Hispanic or Latino | 349 (12.2%) |
| Asian | 153 (5.4%) |
| Non-Hispanic other/unknown | 43 (1.5%) |
| Payor∗ n (%) | |
| Uninsured | 66 (2.3%) |
| Medicare | 1180 (41.3%) |
| Medicaid | 267 (9.3%) |
| Employer | 1531 (53.6%) |
| Direct purchase | 383 (13.4%) |
| Military/Indian Health Service/other | 354 (12.4%) |
| Education, n (%) | |
| < High school | 131 (4.6%) |
| High school diploma or GED | 351 (12.3%) |
| Some college or post-high school training | 766 (26.8%) |
| College degree or higher | 1553 (54.4%) |
| Other/missing | 56 (2.0%) |
| Annual household income, n (%) | |
| <$20K | 286 (10.0%) |
| $20 to $49K | 559 (19.6%) |
| $50 to $74K | 449 (15.7%) |
| $75 to $99K | 372 (13.0%) |
| >$100K | 781 (27.3%) |
| Don’t know/ prefer not to answer/missing | 410 (14.4%) |
| Marital status, n (%) | |
| Never married | 487 (17.0%) |
| Married | 1780 (62.3%) |
| Divorced/separated/widowed/other/missing | 590 (20.7%) |
| ADI national ranking (percentile) | |
| Median (IQR) | 24 (10-46) |
| Donor relation, n (%) | |
| Related | 826 (28.9%) |
| Unrelated | 654 (22.9%) |
| Autologous | 1377 (48.2%) |
| Stem cell source, n (%) | |
| Peripheral blood stem cells | 1995 (69.8%) |
| Bone marrow | 669 (23.4%) |
| Cord blood | 193 (6.8%) |
| Conditioning regimen, n (%) | |
| Myeloablative | 2170 (76.0%) |
| Non-myeloablative or reduced intensity | 687 (24.0%) |
| Chronic graft-versus-host disease (among allogeneic BMT), n (%) | |
| Yes | 822 (55.5%) |
| Chronic conditions summative index | |
| Median (IQR) | 5 (2-8) |
| Diagnosis, n (%) | |
| Acute lymphoblastic leukemia | 231 (8.1%) |
| Acute myeloid leukemia or myelodysplastic syndrome | 716 (25.1%) |
| Chronic myelogenous leukemia | 235 (8.2%) |
| Hodgkin/non-Hodgkin lymphoma | 954 (33.4%) |
| Other leukemia/severe aplastic anemia/other | 241 (8.4%) |
| Plasma cell dyscrasias | 480 (16.8%) |
| Variables . | n (%) . |
|---|---|
| Sex | |
| Male | 1535 (53.7%) |
| Age at study participation in years | |
| Median (interquartile range [IQR]) | 47 (30-58) |
| Time from transplant in years | |
| Median (IQR) | 9 (5-16) |
| Race/ethnicity, n (%) | |
| Non-Hispanic White | 2176 (76.2%) |
| Black or African American | 136 (4.8%) |
| Hispanic or Latino | 349 (12.2%) |
| Asian | 153 (5.4%) |
| Non-Hispanic other/unknown | 43 (1.5%) |
| Payor∗ n (%) | |
| Uninsured | 66 (2.3%) |
| Medicare | 1180 (41.3%) |
| Medicaid | 267 (9.3%) |
| Employer | 1531 (53.6%) |
| Direct purchase | 383 (13.4%) |
| Military/Indian Health Service/other | 354 (12.4%) |
| Education, n (%) | |
| < High school | 131 (4.6%) |
| High school diploma or GED | 351 (12.3%) |
| Some college or post-high school training | 766 (26.8%) |
| College degree or higher | 1553 (54.4%) |
| Other/missing | 56 (2.0%) |
| Annual household income, n (%) | |
| <$20K | 286 (10.0%) |
| $20 to $49K | 559 (19.6%) |
| $50 to $74K | 449 (15.7%) |
| $75 to $99K | 372 (13.0%) |
| >$100K | 781 (27.3%) |
| Don’t know/ prefer not to answer/missing | 410 (14.4%) |
| Marital status, n (%) | |
| Never married | 487 (17.0%) |
| Married | 1780 (62.3%) |
| Divorced/separated/widowed/other/missing | 590 (20.7%) |
| ADI national ranking (percentile) | |
| Median (IQR) | 24 (10-46) |
| Donor relation, n (%) | |
| Related | 826 (28.9%) |
| Unrelated | 654 (22.9%) |
| Autologous | 1377 (48.2%) |
| Stem cell source, n (%) | |
| Peripheral blood stem cells | 1995 (69.8%) |
| Bone marrow | 669 (23.4%) |
| Cord blood | 193 (6.8%) |
| Conditioning regimen, n (%) | |
| Myeloablative | 2170 (76.0%) |
| Non-myeloablative or reduced intensity | 687 (24.0%) |
| Chronic graft-versus-host disease (among allogeneic BMT), n (%) | |
| Yes | 822 (55.5%) |
| Chronic conditions summative index | |
| Median (IQR) | 5 (2-8) |
| Diagnosis, n (%) | |
| Acute lymphoblastic leukemia | 231 (8.1%) |
| Acute myeloid leukemia or myelodysplastic syndrome | 716 (25.1%) |
| Chronic myelogenous leukemia | 235 (8.2%) |
| Hodgkin/non-Hodgkin lymphoma | 954 (33.4%) |
| Other leukemia/severe aplastic anemia/other | 241 (8.4%) |
| Plasma cell dyscrasias | 480 (16.8%) |
GED, general education diploma; BMT, blood marrow transplantation.
Patients may select multiple payors.